Christopher H Van Dyck

Cognition Therapeutics, Inc.

NIH Rank #198
  • Top 1% Funded
  • Program Leader
  • R01 Holder
  • Early Career

NIH Funding · FY2024

Total Funding
$14.1M
Fiscal year 2024
Grants Awarded
3
Active NIH grants
National Rank
#198
Among 57,894 PIs
First NIH Award
2024
Year of first funding

Funding & rank history

NIH funding totals and national rank by fiscal year.

Single fiscal year on record (FY2024): $14.1M across 3 grants · National rank #198.

Top grants by award amount

Christopher H Van Dyck's NIH grant portfolio, ranked by award amount.

  • 5R01AG065248-03R01
    Randomized Double Blind, Placebo Controlled, Parallel Group Trial to Evaluate the Safety and Efficacy of CT1812 in Early Alzheimer's Disease over 18 Months
    $13.1M
    award amount
  • 5R01AG065474-05R01
    Validation of Fluorine-18 radioligand for PET imaging of synaptic density in Alzheimer's disease
    $764.4K
    award amount
  • 5P30AG066508-05P30
    Yale Alzheimer Disease Research Center
    $189K
    award amount

Affiliations

Institutions that have administered grants for Christopher H Van Dyck.

Career milestones

Key NIH funding milestones over time.

  1. 2024
    First NIH Award
    Cognition Therapeutics, Inc.
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    $5M Cumulative Funding
  6. 2024
    $10M Cumulative Funding
  7. 2024
    Entered Top 50% Nationally
    Ranked #198
  8. 2024
    Entered Top 25% Nationally
    Ranked #198
  9. 2024
    Entered Top 10% Nationally
    Ranked #198
  10. 2024
    Entered Top 5% Nationally
    Ranked #198
  11. 2024
    Entered Top 1% Nationally
    Ranked #198
  12. 2024
    Multi-Institutional Research
    Awards at 2 institutions

Related investigators

Other NIH-funded PIs frequently associated with Christopher H Van Dyck.